Standex International Corp: Form 10-Q for the period ended Mar 31, 2024
Filed with the SEC on May 3, 2024 and accepted by EDGAR at May 3, 2024, 13:31 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-01-01 to 2024-03-31 | $177.3m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Revenue | 9 months2023-07-01 to 2024-03-31 | $540.4m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Cost of revenue | 3 months2024-01-01 to 2024-03-31 | $109.0m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2023-07-01 to 2024-03-31 | $327.9m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2024-01-01 to 2024-03-31 | $68.3m | us-gaap:GrossProfit |
| Gross profit | 9 months2023-07-01 to 2024-03-31 | $212.6m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2024-01-01 to 2024-03-31 | $41.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2023-07-01 to 2024-03-31 | $128.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2024-01-01 to 2024-03-31 | $21.8m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2023-07-01 to 2024-03-31 | $74.6m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2024-01-01 to 2024-03-31 | $949.0k | us-gaap:InterestExpense |
| Interest expense | 9 months2023-07-01 to 2024-03-31 | $3.2m | us-gaap:InterestExpense |
| Income tax | 3 months2024-01-01 to 2024-03-31 | $4.3m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2023-07-01 to 2024-03-31 | $15.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-01-01 to 2024-03-31 | $15.8m | us-gaap:NetIncomeLoss |
| Net income | 9 months2023-07-01 to 2024-03-31 | $53.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-01-01 to 2024-03-31 | $1.33 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2023-07-01 to 2024-03-31 | $4.50 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-01-01 to 2024-03-31 | $1.34 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2023-07-01 to 2024-03-31 | $4.55 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-01-01 to 2024-03-31 | 11,849,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2023-07-01 to 2024-03-31 | 11,876,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2023-07-01 to 2024-03-31 | $64.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2023-07-01 to 2024-03-31 | $13.8m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 9 months2023-07-01 to 2024-03-31 | $10.4m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2023-07-01 to 2024-03-31 | $31.8m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2024-03-31 | $138.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-03-31 | $419.2m | us-gaap:AssetsCurrent |
| Total assets | At period end2024-03-31 | $993.5m | us-gaap:Assets |
| Current liabilities | At period end2024-03-31 | $122.3m | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2024-03-31 | $148.8m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2024-03-31 | $619.0m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001437749-24-014596. Last ingested by Listed: Nov 4, 2026, 11:15 ET. Listed shows no prices and gives no investment advice.